Southampton scientists have found that an immune response in the brain plays a key role in the development of Alzheimer's, and that a vaccine designed to tackle the disease was able to suppress the response.
Aug 14, 2013
0
1
Taiwan Sunday called on citizens to vaccinate their pet cats and dogs against rabies as health officials stepped up attempts to combat the deadly disease following a string of outbreaks among wild ferret-badgers.
Jul 28, 2013
0
0
Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more natural alternative.
Jul 17, 2013
1
1
A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer's disease, according to Northwestern Medicine research.
Jun 26, 2013
0
0
(Medical Xpress)—Resolvins are molecules naturally produced by the body from omega-3 fatty acids - a process that can be jumpstarted by common aspirin. In a new study, published in The FASEB Journal, researchers at Karolinska ...
May 27, 2013
0
1
New diseases grab headlines. The latest influenza scare – H7N9 – has prompted much speculation about the direction the virus might take. And rightly so, as vaccines to fight new viruses can take some time to be produced. ...
Apr 25, 2013
0
0
Even a mild injury to the brain can have long lasting consequences, including increased risk of cognitive impairment later in life. While it is not yet known how brain injury increases risk for dementia, there are indications ...
Apr 15, 2013
0
0
(Medical Xpress)—An Australian study has shown that plaque, long considered to be the hallmark of Alzheimer's disease, is one of the last events to occur in the Alzheimer's brain. This finding will impact the current debate ...
Apr 3, 2013
0
0
(Medical Xpress)—New research from the University of Adelaide has shown for the first time that the growth of brain tumours can be halted by a drug currently being used to help patients recover from the side effects of ...
Mar 18, 2013
0
0
(AP)—Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri.
Mar 4, 2013
0
0
